The consumption of dietary supplement in Western Europe is estimated to expand at a promising CAGR of 8.2% through 2033. The sales of dietary supplement in Western Europe are expected to reach a valuation of US$ 35,578.05 million by 2033, up from 16,185.60 in 2023.
Western Europe holds significant potential for manufacturers to expand their business operations. Consequently, they are diversifying their product lines, covering broader segment such as sports and energy, joint health, liver and detox, mental health, etc., to attract more customers. Additionally, leading competitors are fostering intense competition in the region by innovating more complex dietary supplement.
Attributes | Details |
---|---|
Industry Size of Dietary Supplement in Western Europe (2023) | US$ 16,185.60 million |
Expected Industry Size of Dietary Supplement in Western Europe (2033) | US$ 35,578.05 million |
Forecast CAGR between 2023 to 2033 | 8.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Country | Italy |
---|---|
Forecast CAGR % (2023 to 2033) | 6.70% |
Consumption rate of dietary supplement in Italy is predicted to register a CAGR of 6.70% through 2033. Following factors are appreciating the industry worth in Italy:
Country | Germany |
---|---|
Forecast CAGR % (2023 to 2033) | 5.80% |
The adoption of dietary supplement in Germany is increasing at a speed of 5.80 % CAGR through 2033. Given below are the leading factors that are pushing the sales of dietary supplement:
Country | United Kingdom |
---|---|
Forecast CAGR % (2023 to 2033) | 7.90% |
Sales of dietary supplement in the United Kingdom are predicted to expand at a CAGR of 7.90% through 2033. Following factors support product sales in this country:
Country | The Netherlands |
---|---|
Forecast CAGR % (2023 to 2033) | 7.10% |
Consumption of dietary supplement in the Netherlands is expected to surge at a CAGR of 7.10% through 2033. Mentioned below are the leading factors inducing sales of dietary supplement:
Country | France |
---|---|
Forecast CAGR % (2023 to 2033) | 6.30% |
The adoption rate of dietary supplement in France is predicted to record a CAGR of 6.30% through 2033. The following factors augment the sales of dietary supplement:
Leading Form | Soft Gel/ Pills |
---|---|
Value Share % (2023) | 57.80% |
The soft gels/pills segment accounts for a value share of 57.80% in 2023. The segment's growth is driven by the availability of a variety of multivitamin options in the form of soft gels and capsules. Their user-friendly format and easy consumption contribute to the increasing demand for soft gels and pills. Consumers, especially those with swallowing issues, favor soft gels and pills due to their effortless swallowability and gel-like consistency.
Cost-effectiveness, extended shelf life, and convenient packaging of soft gels and capsule supplement are also enhancing the segment's growth. Soft gels and capsules feature well-defined dosages, differentiating them from liquid dietary supplement and contributing to their greater prevalence in Europe.
Leading Ingredient | Amino Acids |
---|---|
Value Share % (2023) | 41.70% |
As per our study, amino acids account for a share of 41.70% in 2023. Amino acids are recommended for patients suffering from chronic disorders like heart disease, diabetes, and cancer, as these diseases typically have a debilitating effect on the body’s ability to absorb and utilize amino acids. Additionally, the growing popularity of sports and fitness in Western Europe is fueling the consumption of amino acid supplement among athletes and gym-goers.
Private enterprises, as well as public corporations in Western Europe, are intensifying their commitment to innovation and quality, both of which are crucial to ensuring brand reputation. Leading players are emphasizing the improvement of their product offerings. In addition to this, companies are dedicating their research and development efforts to seamlessly integrate cutting-edge technologies, reflecting their dedication to providing high-quality dietary supplement.
Key Development Spurring the Sales of Dietary Supplement in Western Europe
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Attribute | Details |
---|---|
Estimated Industry Size in 2023 | US$ 16,185.60 million |
Projected Industry Size by 2033 | US$ 35,578.05 million |
Anticipated CAGR between 2023 to 2033 | 8.2% CAGR |
Historical Analysis of Demand for Dietary Supplement in Western Europe | 2018 to 2022 |
Demand Forecast for Dietary Supplement in Western Europe | 2023 to 2033 |
Report Coverage of Dietary Supplement in Western Europe | Industry Size, Industry Trends, Analysis of Key Factors Influencing Dietary Supplement Adoption in Western Europe, Insights on Western Europe Players and their Industry Strategy in Western Europe, Ecosystem Analysis of Local and Regional Western Europe Providers |
Key Countries Analyzed While Studying Opportunities for Dietary Supplement in Western Europe |
|
Key Companies Profiled for Dietary Supplement in Western Europe |
|
The anticipated CAGR through 2033 is 8.2%.
Demand for dietary supplement in Western Europe is expected to reach US$ 35,578.05 million by 2033.
Manufacturers are turning to investment strategy to compete in the region.
Soft gels/pills is prominently consumed by population in Western Europe.
Amino acids take a considerable share of the dietary supplement industry.
1. Executive Summary
1.1. Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units pack) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Ingredients
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units pack) Analysis By Ingredients , 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units pack) Analysis and Forecast By Ingredients , 2023 to 2033
5.3.1. Amino Acid
5.3.2. Animal Extract
5.3.3. Botanical Extract
5.3.4. Mineral
5.3.5. Nucleotide
5.3.6. Omega 3
5.3.7. Probiotics
5.3.8. Protein
5.3.9. Sugar
5.3.10. Vegetable Oil & Powder
5.3.11. Vitamin
5.3.12. Yeast Extract
5.4. Y-o-Y Growth Trend Analysis By Ingredients , 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Ingredients , 2023 to 2033
6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units pack) Analysis By Form, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units pack) Analysis and Forecast By Form, 2023 to 2033
6.3.1. Soft Gel/Pills
6.3.1.1. Confectionery Products
6.3.1.2. Pharmaceuticals Products
6.3.2. Powder
6.3.3. Liquid
6.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033
7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units pack) Analysis By Application , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units pack) Analysis and Forecast By Application , 2023 to 2033
7.3.1. Weight Loss
7.3.2. Sports Nutrition’s
7.3.3. General Well-Beings
7.3.4. Immune & Digestive Health
7.3.5. Bone & Joint Health
7.3.6. Heart Health
7.3.7. Others Specific Requirements (Supplements ,Anti -Allergies & EyeHealth)
7.4. Y-o-Y Growth Trend Analysis By Application , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033
8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units pack) Analysis By Country, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units pack) Analysis and Forecast By Country, 2023 to 2033
8.3.1. UK
8.3.2. Germany
8.3.3. Italy
8.3.4. France
8.3.5. Spain
8.3.6. Rest of Western Europe
8.4. Market Attractiveness Analysis By Country
9. UK Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Region
9.2.1.1. England
9.2.1.2. Scotland
9.2.1.3. Wales
9.2.1.4. Northern Ireland
9.2.2. By Ingredients
9.2.3. By Form
9.2.4. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Region
9.3.2. By Ingredients
9.3.3. By Form
9.3.4. By Application
9.4. Key Takeaways
10. Germany Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
10.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Region
10.2.1.1. North-east (Germany)
10.2.1.2. North-west (Germany)
10.2.1.3. Central (Germany)
10.2.1.4. South (Germany)
10.2.1.5. Other(Germany)
10.2.2. By Ingredients
10.2.3. By Form
10.2.4. By Application
10.3. Market Attractiveness Analysis
10.3.1. By Region
10.3.2. By Ingredients
10.3.3. By Form
10.3.4. By Application
10.4. Key Takeaways
11. Italy Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
11.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Region
11.2.1.1. North (Italy)
11.2.1.2. Central (Italy)
11.2.1.3. South (Italy)
11.2.1.4. Islands (Italy)
11.2.2. By Ingredients
11.2.3. By Form
11.2.4. By Application
11.3. Market Attractiveness Analysis
11.3.1. By Region
11.3.2. By Ingredients
11.3.3. By Form
11.3.4. By Application
11.4. Key Takeaways
12. France Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
12.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Region
12.2.1.1. Northern (France)
12.2.1.2. Central (France)
12.2.1.3. Southern (France)
12.2.1.4. Eastern (France)
12.2.2. By Ingredients
12.2.3. By Form
12.2.4. By Application
12.3. Market Attractiveness Analysis
12.3.1. By Region
12.3.2. By Ingredients
12.3.3. By Form
12.3.4. By Application
12.4. Key Takeaways
13. Spain Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
13.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Region
13.2.1.1. Basque Country
13.2.1.2. Andalusia
13.2.1.3. Extremadura
13.2.1.4. Catalonia
13.2.1.5. Valencia
13.2.1.6. Rest of Spain
13.2.2. By Ingredients
13.2.3. By Form
13.2.4. By Application
13.3. Market Attractiveness Analysis
13.3.1. By Region
13.3.2. By Ingredients
13.3.3. By Form
13.3.4. By Application
13.4. Key Takeaways
14. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
14.1. Historical Market Size Value (US$ Million) & Volume (Units pack) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units pack) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Ingredients
14.2.2. By Form
14.2.3. By Application
14.3. Market Attractiveness Analysis
14.3.1. By Ingredients
14.3.2. By Form
14.3.3. By Application
14.4. Key Takeaways
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Ingredients
15.3.3. By Form
15.3.4. By Application
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Amway Corp.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Glanbia PLC
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Abbott
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Bayer AG
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Pfizer Inc.
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. ADM
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Nu Skin Enterprises, Inc.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. GlaxoSmithKline plc
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. Bionova
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. Ayanda
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
16.1.11. Arkopharma
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.11.5.2. Product Strategy
16.1.11.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Food and Beverage Insights
View Reports